Innate Pharma
IPHA
#8501
Rank
C$0.18 B
Marketcap
$2.27
Share price
3.82%
Change (1 day)
-31.20%
Change (1 year)

P/S ratio for Innate Pharma (IPHA)

P/S ratio at the end of 2022: 5.63

According to Innate Pharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.30. At the end of 2022 the company had a P/S ratio of 5.63.

P/S ratio history for Innate Pharma from 2006 to 2022

PS ratio at the end of each year

Year P/S ratio Change
20225.63-80.74%
202129.2499.83%
20204.87-28.87%
20196.8514.91%
20185.96-28.38%
20178.32-40.95%
201614.1-65.38%
201540.7-91.17%
20144612436%
201318.2129.2%
20127.9349.23%
20115.31-47.74%
201010.2-13.41%
200911.7326.27%
20082.76-37.43%
20074.40-65.51%
200612.8